Media and News
PharmaNova to Present at the Biotechnology Symposium held at the Oncenter Complex, Syracuse NY, May 21-22 2012.
PharmaNova Inc. will be presenting at the Biotechnology Symposium held at the Oncenter Complex in Syracuse, NY held on May 21-22 2012. The presentation entitled “The Increasing Influence of Nanoparticle Technology on Pharmaceutical Formulation Science and Drug Delivery” is part of the session focused on nanoparticulate drug delivery. The 2012 Biotechnology Symposium is sponsored by the University of New York College of Environmental Science and Forestry and the Upstate Medical Center of Syracuse University and features scientific and business leaders from Central New York’s Developing Biosciences Cluster and Central New York’s New Bio-incubator and Business Accelerator.
PharmaNova Inc. is a privately held pharmaceutical company. Our product candidates are derived from the re‐positioning and enhancement of known drugs using our proprietary NovaSperse℠ nanoparticle technology platform. We address low risk, fast to market products in areas of clear medical need and generate revenue from partnering and licensing strategies with commercialization partners and clients worldwide. PharmaNova also conducts contractual formulation development work applying NovaSperse℠ technology to client‐owned products and compounds to support new product development or the extended life cycle management of existing products. PharmaNova has other new product candidates in various stages in its development pipeline. Our focus is on the development of novel, improved nanoparticle formulations of ophthalmic and anti-infective products.
« Back to Media
Member of the media wishing to learn more about Pharmanova should contact:
Rafael Larramendi, President | firstname.lastname@example.org | (585) 919 -9649.